BEVERAGE CONTAINING HYDROXYTYROSOL
    1.
    发明申请

    公开(公告)号:US20190124952A1

    公开(公告)日:2019-05-02

    申请号:US15779803

    申请日:2016-11-28

    IPC分类号: A23L2/56 A23L29/00 A23L33/105

    摘要: The present invention has as its objects to provide beverages that contain hydroxytyrosol but are comfortable to drink, and to provide a method for reducing the hydroxytyrosol-derived harshness and off-flavor of a hydroxytyrosol-containing beverage. A beverage comprising 0.5 to 50 mg/100 mL of hydroxytyrosol, and further comprising ethanol and/or propylene glycol. A beverage comprising 0.5 to 50 mg/100 mL of hydroxytyrosol, and further comprising caffeine. A beverage comprising 0.5 to 50 mg/100 mL of hydroxytyrosol, and further comprising glucose and maltose at a (weight) ratio of [glucose]/[maltose] of 0.001 to 1.

    NOVEL GLYCOSYLTRANSFERASE GENE AND USE THEREOF
    3.
    发明申请
    NOVEL GLYCOSYLTRANSFERASE GENE AND USE THEREOF 审中-公开
    新型GLYCOSYLTRANSFERASE基因及其用途

    公开(公告)号:US20170058269A1

    公开(公告)日:2017-03-02

    申请号:US15308117

    申请日:2015-05-01

    IPC分类号: C12N9/10 C12P17/06

    摘要: Provided is a polynucleotide for encoding a protein that exhibits activity for transferring a sugar to a hydroxyl group at position 7 of a flavone, particularly flavone 4′-glucoside. A polynucleotide selected from the group consisting of: (a) polynucleotides comprising a base sequence of SEQ ID NO.: 1 or SEQ ID NO.: 5; (b) polynucleotides that hybridize, under stringent conditions, with polynucleotides comprising a base sequence complementary to a base sequence of SEQ ID NO.: 1 or SEQ ID NO.: 5, wherein the polynucleotides encode a protein that exhibits activity for transferring a sugar to a hydroxyl group at position 7 of a flavone; (c) polynucleotides for encoding proteins comprising an amino acid sequence of SEQ ID NO.: 2 or SEQ ID NO.: 6; (d) polynucleotides for encoding proteins comprising an amino acid sequence in which one or more amino acids have been deleted, substituted, inserted, and/or added in an amino acid sequence of SEQ ID NO.: 2 or SEQ ID NO.: 6, the polynucleotides exhibiting activity for transferring a sugar to a hydroxyl group at position 7 of a flavone; and the like.

    摘要翻译: 本发明提供一种编码蛋白质的多核苷酸,其表现出将糖转移到黄酮,特别是黄酮4'-葡萄糖苷的第7位的羟基的活性。 选自以下的多核苷酸:(a)包含SEQ ID NO:1或SEQ ID NO:5的碱基序列的多核苷酸; (b)在严格条件下与包含与SEQ ID NO:1或SEQ ID NO:5的碱基序列互补的碱基序列的多核苷酸杂交的多核苷酸,其中所述多核苷酸编码显示转移糖的活性的蛋白质 到黄酮的第7位的羟基; (c)编码包含SEQ ID NO:2或SEQ ID NO:6的氨基酸序列的蛋白质的多核苷酸; (d)用于编码蛋白质的多核苷酸,其包含其中一个或多个氨基酸已被缺失,取代,插入和/或加入到SEQ ID NO:2或SEQ ID NO:6的氨基酸序列中的氨基酸序列 表现出将糖转移到黄酮第7位羟基的活性的多核苷酸; 等等。

    INTESTINAL BARRIER FUNCTION ENHANCER CONTAINING LACTIC ACID BACTERIA
    4.
    发明申请
    INTESTINAL BARRIER FUNCTION ENHANCER CONTAINING LACTIC ACID BACTERIA 审中-公开
    含有酸性细菌的肠梗阻功能增强

    公开(公告)号:US20160279181A1

    公开(公告)日:2016-09-29

    申请号:US15032733

    申请日:2014-11-07

    发明人: Hiroyuki HOSHIKO

    IPC分类号: A61K35/747 A23L2/52

    摘要: Provided are an intestinal barrier function enhancer capable of enhancing intestinal barrier function and thereby capable of preventing or treating metabolic syndrome, and a drug and a food or drink containing the same. An intestinal barrier function enhancer containing cells or a treated cell product of Lactobacillus crustorum. This intestinal barrier function enhancer functions effectively to enhance intestinal barrier function and to prevent or treat conditions or diseases caused by impaired intestinal barrier function such as metabolic syndrome and the like.

    摘要翻译: 本发明提供能够增强肠屏障功能,从而能够预防或治疗代谢综合征的肠屏障功能增强剂,以及包含其的药物和食品或饮料。 含有细胞的肠屏障功能增强剂或克隆乳杆菌的经处理的细胞产物。 这种肠屏障功能增强剂有效地起到增强肠屏障功能的作用,并且能够预防或治疗由于肠屏障功能如代谢综合症等引起的病症或疾病。

    Container lid having oxygen shielding properties

    公开(公告)号:US11987424B2

    公开(公告)日:2024-05-21

    申请号:US16971039

    申请日:2018-12-20

    IPC分类号: B65D41/04 C08L23/06

    摘要: An oxygen-shielding container lid according to the present invention comprises a high density polyethylene cap shell 1 having a skirt section 7 and a top plate section 5 provided with an inner ring 9 for intimate contact with an inner surface of a container mouth; and an in-shell molded body 3 provided in a portion of an inner surface of the top plate section which is surrounded with the inner ring 9. The in-shell molded body 3 is composed of a primary molded body 3a which has been formed by in-shell molding on the inner surface of the top plate section and which has an oxygen shielding function; and a secondary molded body 3b which has been formed on the primary molded body 3a by in-shell molding so as to cover the primary molded body 3a and to be fused and fixed to the inner surface of the top plate section at the peripheral edge of the primary molded body. A resin composition used for formation of the secondary molded body 3b contains linear low density polyethylene, and has a melt flow rate at 190° C. of 1 to 10 g/10 minutes, a density of 0.900 to 0.920 g/cm3, and a nominal tensile strain at break, as defined by JIS K-6922-2, of 400% or more.